| Announce Date | 12/04/2025 |
| EPS Normalized Actual | $1.13 (Beat by $0.25) |
| EPS GAAP Actual | $1.13 (Beat by $0.25) |
| Revenue Actual | $1.8882B |
| Revenue Surprise | Beat by $1888.2M |
| Announce Date | 10/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.68208 |
| EPS GAAP Estimate | $2.68208 |
| Revenue Estimate | $2.426055366B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2028 | 6.44131 | 11.33 | 6.07372 | 6.78761 | 16 |
| Jan 2027 | 14.2174 | 5.13 | 13.9368 | 14.99081 | 4 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 0.33 | -1.73332 | 1.8882B | 100% | -556.75M |
| FQ2 2025 (Apr 2025) | 2.06 | 0.05208 | 1.8469B | 100% | 114.87M |
| FQ1 2025 (Jan 2025) | -11.42 | -11.42 | 2.0976B | 100% | 2097.6M |
| FQ4 2024 (Oct 2024) | 0 | 0 | 1.9557B | 100% | 1955.7M |
| FQ2 2012 (Apr 2012) | 0.46 | 0.46 | 0.7627B | 100% | 762.7M |
| FQ3 2012 (Jul 2012) | -0.0237 | -0.0237 | 0.6081B | 100% | 608.1M |
| FQ4 2012 (Oct 2012) | 0.27 | 0.27 | 0.7339B | 100% | 733.9M |
| FQ1 2013 (Jan 2013) | 0.3 | 0.3 | 0.7915B | 100% | 791.5M |
FQ4 Announce Date
10/30/2025 (Pre-Market)
Consensus EPS Estimates
2.68208
Consensus Revenue Estimates
2.426055366B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 2.19379 | -- | 2.13645 | 2.29175 | 1 |
| FQ3 2027 (Jul 2027) | 1.0923 | -- | 1.06375 | 1.14107 | 1 |
| FQ2 2027 (Apr 2027) | 1.18159 | -- | 1.15071 | 1.23435 | 1 |
| FQ1 2027 (Jan 2027) | 3.43504 | -- | 3.15752 | 3.86393 | 0 |
| FQ4 2026 (Oct 2026) | 2.96338 | -- | 2.72397 | 3.33338 | 1 |
| FQ3 2026 (Jul 2026) | 2.76455 | 88.06 | 2.5412 | 3.10973 | 1 |
| FQ2 2026 (Apr 2026) | 2.3552 | 12.53 | 2.10277 | 2.67501 | 5 |
| FQ1 2026 (Jan 2026) | 3.09746 | 468.69 | 2.84721 | 3.48421 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Oct 2027) | 2.47B | -- | 2.42B | 2.55B | 1 |
| FQ3 2027 (Jul 2027) | 2.07B | -- | 2.03B | 2.14B | 1 |
| FQ2 2027 (Apr 2027) | 2.08B | -- | 2.03B | 2.15B | 1 |
| FQ1 2027 (Jan 2027) | 3.01B | -- | 2.82B | 3.3B | 1 |
| FQ4 2026 (Oct 2026) | 2.9B | -- | 2.72B | 3.18B | 2 |
| FQ3 2026 (Jul 2026) | 2.8B | 32.58 | 2.63B | 3.07B | 2 |
| FQ2 2026 (Apr 2026) | 3.71B | 50.23 | 3.4B | 4.1B | 3 |
| FQ1 2026 (Jan 2026) | 2.74B | 23.56 | 2.57B | 3.01B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 2.06332 | 0.33 | -1.73332 | -525.25% |
| FQ2 2025 (Apr 2025) | 2.00792 | 2.06 | 0.05208 | 2.53% |
| FQ1 2025 (Jan 2025) | -11.42 | -11.42 | 100% | |
| FQ4 2024 (Oct 2024) | 0 | 0 | NAN% | |
| FQ2 2012 (Apr 2012) | 0.46 | 0.46 | 100% | |
| FQ3 2012 (Jul 2012) | -0.0237 | -0.0237 | 100% | |
| FQ4 2012 (Oct 2012) | 0.27 | 0.27 | 100% | |
| FQ1 2013 (Jan 2013) | 0.3 | 0.3 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | $2.44B | $1.89B | $-556.75M | -29.49% |
| FQ2 2025 (Apr 2025) | $1.73B | $1.85B | $114.87M | 6.22% |
| FQ1 2025 (Jan 2025) | $0B | $2.1B | $2097.6M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $1.96B | $1955.7M | 100% |
| FQ2 2012 (Apr 2012) | $0B | $0.76B | $762.7M | 100% |
| FQ3 2012 (Jul 2012) | $0B | $0.61B | $608.1M | 100% |
| FQ4 2012 (Oct 2012) | $0B | $0.73B | $733.9M | 100% |
| FQ1 2013 (Jan 2013) | $0B | $0.79B | $791.5M | 100% |